Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Regulus Therapeutics
Biotech
Sanofi walks away from Regulus' kidney disease therapy
Sanofi is letting go of a genetic kidney disease therapy under development with Regulus Therapeutics after getting a peak at an interim analysis.
Annalee Armstrong
Jul 18, 2022 2:40pm
Regulus again reprioritizes in attempt to turn ship around
Oct 13, 2021 11:18am
Boehringer, Dicerna pen $201M pact to hit NASH with RNAi
Nov 2, 2017 6:30am
Chutes & Ladders—Biogen’s longtime CFO Clancy leaves for Alexion
Jun 16, 2017 8:39am
Regulus taps Aptuit to help advance pipeline
Jun 14, 2017 11:37am
Struggling Regulus promotes ex Lilly exec as new CMO
Jun 13, 2017 9:28am
